Projecting future drug expenditures in U.S. nonfederal hospitals and clinics—2013
James M. Hoffman(St. Jude Children's Research Hospital), Glen T. Schumock(University of Illinois Chicago), Robert J. Hunkler(IQVIA (United States)), Linda M. Matusiak(IQVIA (United States)), Lee C. Vermeulen(American Association of Colleges of Pharmacy), Fred Doloresco(University at Buffalo, State University of New York), Nilay D. Shah(Mayo Clinic), Edward Li(Sanden (Japan))
Cited by 22
Related Papers
PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2014|277
Synergistic Function of E2F7 and E2F8 Is Essential for Cell Survival and Embryonic Development
|Developmental Cell|2008|231
Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death
|The Journal of Cell Biology|2017|175
Characterizing the demographics of chronic pain patients in the state of Maine using the Maine all payer claims database
|BMC Public Health|2018|85
Projecting future drug expenditures—2012
|American Journal of Health-System Pharmacy|2012|81